Impact of therapeutic research on informed consent and the ethics of clinical trials: A Medical Oncology Perspective

Journal of Clinical Oncology

Volumn 17, Issue 5, 1999, Pages 1601-1617

  Daugherty, Christopher K ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATHY; ARTICLE; CANCER PATIENT; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; PATIENT ATTITUDE; PRIORITY JOURNAL;

EID: 0032922146     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.5.1601     Document Type: Article

References (158)

1. Faden RR, Beauchamp TL, King NMP: A History and Theory of Informed Consent. New York, NY, Oxford University Press, 1986
2. Applebaum PS, Lindz CN, Meisel A: Informed Consent: Legal Theory and Clinical Practice. New York, NY, Oxford University Press, 1987
3. Levine RJ: Ethics and Regulation of Clinical Research (ed 2). Baltimore, MD, Vurland and Schwarzenburg, 1986
4. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Publication no. (05) 78-0012. Washington, DC, United States Government Printing Office, 1978
5. Freedman B, Fuks A, Weijer C: Demarcating research in treatment: A systematic approach for the analysis of the ethics of clinical research. Clin Res 40:655-660, 1992
6. Bok S: Shading the truth in informed consent for clinical research. Kennedy Inst Ethics J 5:1-17, 1995
7. Pelligrino ED: Beneficence, scientific autonomy, and self-interest: Ethical dilemmas in clinical research. Camb Q Healthc Ethics 1:361-369, 1992
8. Jonsen AR, Siegler M, Winslade WJ: Clinical Ethics (ed 3). New York, NY, McGraw-Hill, 1992, pp 146-149
9. Schaffner KF: Ethical problems in clinical trials. J Med Philos 11:297-315, 1986
10. Markman M: The objective clinical scientist versus the advocate: A complex ethical and political dilemma facing cancer investigators and the public. Cancer Invest 13:324-326, 1995
11. Elks ML: Conflict of interest and the physician-researcher. J Lab Clin Med 126:19-23, 1995
12. Hammerschmidt DE: When commitments and interests conflict. J Lab Clin Med 126:5-6, 1995
13. Levine RJ: Clinical trials and physicians as double agents. Yale J Biol Med 65:65-74, 1992
14. Katz J: Experimentation With Human Beings. New York, NY, Russell Sage Foundation, 1972
15. Annas GJ: The changing landscape of human experimentation: Nuremberg, Helsinki, and beyond. J Law Med 2:119-140, 1992
16. The President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Implementing Human Research Regulations: The Adequacy and Uniformity of Federal Rules and Their Implementation. Publication no. 040-000-1 00471-8. Washington, DC, United States Government Printing Office, 1983
17. Epstein LC, Lasagna L: Obtaining informed consent, form or substance. Arch Intern Med 123:682-688, 1969
18. Gray BH, Cooke RA, Tannebaum AS: Research involving human subjects: The performance of institutional review boards is assessed in this empirical study. Science 201:1094-1101, 1978
19. Goldman J, Katz MD: Inconsistency and institutional review boards. JAMA 248:197-202, 1982
20. Hammerschmidt DE, Keanse MA: Institutional review board review lacks impact on the readability of consent forms for research. Am J Med Sci 304:341-351, 1992
21. Edgar H, Rothman DJ: The institutional review board and beyond: Future challenges to the ethics of human experimentation. Milbank Q 73:489-506, 1995
22. Redshaw ME, Harris A, Baum JD: Research ethics committee audit: Differences between committees. J Med Ethics 22:78-82, 1996
23. Daugherty CK, Ratain MJ, Siegler M: Ethical issues in the clinical research of cancer, in Devita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia PA, Lippincott, 1997, pp 534-542
24. Kent G: Shared understandings for informed consent: The relevance of psychological research on the provision of information. Soc Sci Med 43:1517-1524, 1996
25. Verheggen FWSM, van Wijmen FCB: Informed consent in clinical trials. Health Policy 36:131-153, 1996
26. Katz J: Human experimentation and human rights. St Louis Univ Law J 38:7-54, 1993
27. Engelhardt HT: The Foundations of Bioethics (ed 2). New York, NY, Oxford University Press, 1996, pp 330-335
28. Jonas H: Philosophical reflections on experimenting with human subjects, in Freund PA (ed): Experimentation With Human Subjects. New York, NY, George Brazilier, 1969
29. Advisory Committee on Human Radiation Experiments: The Final Report of the President's Advisory Committee on the Human Radiation Experiments. New York, NY, Oxford University Press, 1996
30. Lederer SE: Subjected to Science: Human Experimentation in America Before the Second World War. Baltimore, MD, Johns Hopkins University Press, 1995
31. Howard-Jones N: Human experimentation in historical and ethical perspectives. Soc Sci Med 16:1429-1448, 1982
32. Salgo v Leland Stanford Jr, the University Board of Trustees, 317 P2nd 170, 1957
33. Katz J: The Silent World of Doctor and Patient. New York, NY, The Free Press, 1984
34. Obituary: Gebhard PG, 69, developer of the term "informed consent." New York Times, August 26, 1997
35. Advisory Committee on Human Radiation Experiments: The Final Report of the President's Advisory Committee on the Human Radiation Experiments. New York, NY, Oxford University Press, 1996, pp 46-67
36. Bean WB: Walter Reed and the ordeal of human experimentation. Bull Hist Med 51:75-92, 1977
37. Sass HM: Reichsrundschreiben 1931: Pre-Nuremberg German regulations concerning new therapy and human experimentation. J Med Philos 8:99-111, 1983
38. Vollmann J, Winau R: The Prussian regulation of 1900: Early ethical standards for human experimentation in Germany. IRB 18:9-11, 1996
39. Beecher HK: Ethics in clinical research. N Engl J Med 274:1354-1360, 1966
40. Rothman DJ: Ethics and human experimentation: Henry Beecher revisited. N Engl J Med 317:1195-1199, 1987
41. Jones JH: Bad Blood (ed 2). New York, NY, Free Press 1993
42. Advisory Committee on Human Radiation Experiments: The Final Report of the President's Advisory Committee on the Human Radiation Experiments. New York, NY, Oxford University Press, 1996, pp 98-99
43. Muss HB, White DR, Michielutte R, et al: Written informed consent in patients with breast cancer. Cancer 43:1549-1556, 1979
44. LoVerde ME, Prochazka AV, Byyny RL: Research consent forms: Continued unreadability and increasing length. J Gen Intern Med 4:410-412, 1989
45. Grossman SA, Piantadosi S, Covahey C: Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol 12:2211-2215, 1994
46. Sutherland H: Are we getting informed consent from patients with cancer? J Royal Soc Med 83:439-443, 1990
47. Rimer B, Jones W, Keintz M, et al: Informed consent: A crucial step in cancer patient education. Health Educ Q 10:30-42, 1984
48. Aaronson N, Zittoun R: Informed consent in cancer clinical trials, in Holland J, Zittoun R (eds): Psychological Aspects of Oncology. New York, NY, Springer-Verlag, 1990
49. Taub H, Baker M, Sturr H: Informed consent for research: Effects of readability, patient age, and education. J Am Geriatr Soc 34:601-608, 1986
50. Morrow G, Bennet J, Carpenter P: Informed consent to treatment in clinical trials. Bio Med Pharmacother 37:10-13, 1983
51. Kennedy BJ, Lillehaugen A: Patient recall of informed consent. Med Pediatr Oncol 7:173-178, 1979
52. White D, Muss H, Miechielutte R, et al: Informed consent: Patient information forms in chemotherapy trials. Am J Clin Oncol 7:183-190, 1984
53. Williams C, Zwitter M: Informed consent in European multicenter clinical trials: Are patients really informed? Eur J Cancer 7:907-910, 1994
54. Siminoff L, Fetting J, Abeloff M: Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192-1200, 1989
55. Penman D, Holland J, Bahna G, et al: Informed consent for investigational therapies: Patients' and physicians' perceptions. J Clin Oncol 10:849-855, 1984
56. Jubelirer SJ: Level of reading difficulty in educational pamphlets and informed consent documents for cancer patients. W V Med J 87:554-557, 1991
57. Sutherland HJ, Lockwood GA, Tritchler BL, et al: Communicating probabilistic information to cancer patients: Is there "noise" on the line? Soc Sci Med 32:725-731, 1991
58. Lesko L, Dermatis H, Penman D, et al: Patients: Parents' and oncologists' perceptions of informed consent for bone marrow transplantation. Med Pediatr Oncol 17:181-187, 1989
59. Tarnowski KJ, Allen DM, Mayhall C, et al: Readability of pediatric biomedical research informed consent forms. Pediatrics 85:58-62, 1990
60. Lynoe N, Sandlund M, Dahlqvist G, et al: Informed consent: Study of quality of information given to participants in a clinical trial. BMJ 303:610-613, 1991
61. Olver IN, Buchanan L, Ladlow C, et al: The adequacy of consent forms for informing patients entering oncological clinical trials. Ann Oncol 6:867-870, 1995
62. Llewellyn-Thomas H, McGreal MJ, Thiel EC, et al: Patients' willingness to enter clinical trials: Measuring the association with received benefit and preference for decision participation. Soc Sci Med 32:35-42, 1991
63. Simes RJ, Tattersal MHN, Coates AS, et al: Randomized comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. BMJ 293:1065-1068, 1986
64. Edwards SJL, Lilford RJ, Thornton J, et al: Informed consent for clinical trials: In search of the "best" method. Soc Sci Med 47:1825-1840, 1998
65. Dunn SM, Butow PN, Tattersall MHN, et al: General information tapes inhibit recall of the cancer consultation. J Clin Oncol 11:2279-2285, 1993
66. Deutsch G: Improving communication with oncology patients: Taping the consultation. Clin Oncol 4:46-47, 1992
67. Johnson IA, Adelstein DJ: The use of recorded interviews to enhance physician patient communication. J Cancer Educ 6:99-102, 1991
68. Hogbin B, Fallowfield L: Getting it taped: The "bad news" consultation with cancer patients. Br J Hosp Med 41:330-333, 1989
69. Tattersall MHN, Butow PN, Griffin AM, et al: The take-home message: Patients prefer consultation audio taped to summary letters. J Clin Oncol 12:1305-1311, 1994
70. Llewellyn-Thomas HA, Thiel EC, Semin FWC, et al: Presenting clinical trial information: A comparison of methods. Patient Educ Couns 25:97-107, 1995
71. Agre P, McKee K, Gagon N, et al: Patient satisfaction with an informed consent process. Cancer Pract 5:162-167, 1997
72. Jimison HB, Sher PT, Appleyard R, et al: The use of multimedia in the informed consent process. J Am Med Inform Assoc 5:245-256, 1998
73. Damian D, Tattersall MHN: Letters to patients: Improving communications in cancer care. Lancet 338:923-925, 1991
74. Davis TC, Holcombe RF, Berkel HJ, et al: Informed consent for clinical trials: A comparative study of standard versus simplified forms. J Natl Cancer Inst 90:668-674, 1998
75. Berner ES, Partridge EE, Baum SJ: The effects of the PDQ patient information file (PIF) on patients' knowledge, enrollment in clinical trials and satisfaction. J Cancer Educ 12:121-125, 1997
76. Dodd MJ: Cancer patients' knowledge of chemotherapy: Assessment and informational interventions. Oncol Nurs Forum 9:39-44, 1982
77. Doak LG, Doak CC, Meade CD: Strategies to improve cancer education materials. Oncol Nurs Forum 23:1305-1311, 1996
78. Michielutte R, Bahnson J, Dignan MB, et al: The use of illustrations and narrative text style to improve readability of a health education brochure. J Cancer Educ 7:251-260, 1992
79. Aaronson NK, Visser-Pol E, Leenhouts GHMW, et al: Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 14:984-996, 1996
80. Ratain MJ, Mick R, Schilsky R, et al: Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 85:1637-1643, 1993
81. Vanderpool HY: The Ethics of Research Involving Human Subjects: Facing the 21st Century. Frederick, MD, University Publishing Group, 1996, p 306
82. Freedman B: Cohort-specific consent: An honest approach to phase I cancer studies. IRB 12:5-7, 1990
83. Von Hoff DD, Turner J: Response rates, duration of response, and dose response effect in phase I studies in antineoplastics. Invest New Drugs 9:115-122, 1991
84. Decoster G, Stein G, Holdener EE: Responses and toxic deaths in phase I clinical trials. J Ann Oncol 2:175-181, 1990
85. Estey E, Hoth D, Wittes R, et al: Therapeutic responses in phase I trials of antineoplastic agents. Cancer Treat Rep 70:1105-1115, 1986
86. Smith TL, Lee JJ, Kantarjian HM, et al: Design and results of phase I cancer clinical trials: Three-year experience at M.D. Anderson Cancer Center. J Clin Oncol 14:287-295, 1996
87. Rodenhuis S, van-den Heuvel WJ, Annyas AA, et al: Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol 20:457-462, 1984
88. Willems Y, Sessa C: Informing patients about phase I trials: How should it be done? Acta Oncol 28:106-107, 1989
89. Daugherty CK, Ratain MJ, Grochowski E, et al: Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13:1062-1072, 1995
90. Daugherty CK, Lyman K, Mick R, et al: Differences in perceptions of goals, expectations, and level of informed consent in phase I clinical trials. Proc Am Soc Clin Oncol 15:352a, 1996
91. Daugherty CK, Kialbasa TA, Siegler M, et al: Informed consent in clinical research: A study of cancer patient understanding of consent forms and alternatives of care in phase I clinical trials. Proc Am Soc Clin Oncol 16:188a, 1997
92. Tomamichiel M, Sessa C, Herzig S, et al: Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients. Ann Oncol 6:321-323, 1995
93. Yoder LH, O'Rourke TJ, Ethyre A, et al: Expectations and experiences of patients with cancer participating in phase I clinical trials. Oncol Nurs Forum 24:891-896, 1997
94. Itoh K, Sasaki Y, Fuji H, et al: Patients in phase I trials of anti-cancer agents in Japan: Motivation, comprehension and expectations. Br J Cancer 76:107-113, 1997
95. Seale C: Communication and awareness about death: A study of a random sample of dying people. Soc Sci Med 32:943-952, 1991
96. Hinton J: How reliable are relatives' retrospective reports of terminal illness? Patients' and Relatives' counts compared. Soc Sci Med 43:1229-1236, 1996
97. Mor V, Masterson-Allen S: A comparison of hospice vs conventional care of the terminally-ill cancer patients. Oncology 4:85-91, 1990
98. Trill MD, Holland J: Cross-cultural differences in the care of patients with cancer: A review. Gen Hosp Psychiatry 15:21-30, 1993
99. Schafer A: The ethics of the randomized clinical trial. N Engl J Med 307:719-724, 1982
100. Gifford F: The conflict between randomized clinical trials and the therapeutic obligation. J Med Philos 11:347-366, 1986
101. Kodish E, Lantos JD, Siegler M: Ethical considerations in randomized controlled clinical trials. Cancer 65:2400-2404, 1990 (suppl)
102. Marquis D: Leaving therapy to chance: An impasse in the ethics of clinical trials. Hastings Cent Rep 13:40-47, 1983
103. Hellman S, Hellman DS: Of mice but not men: Problems of the randomized clinical trial. N Engl J Med 324:1585-1589, 1991
104. Markman M: Ethical difficulties with randomized clinical trials involving cancer patients: Examples from the field of gynecologic oncology. J Clin Ethics 3:193-195, 1992
105. Emmanual EJ, Peterson WB: Ethics of randomized clinical trials. J Clin Oncol 16:365-371
106. Fried C: Medical Experimentation: Personal Integrity and Social Policy. Amsterdam, the Netherlands, North Holland Publishing, 1974
107. Freedman B: Equipoise and the ethics of clinical research. N Engl J Med 317:141-145, 1987
108. Gifford F: Community equipoise and the ethics of randomized clinical trials. Bioethics 9:127-148, 1995
109. Freedman B: A response to a purported ethical difficulty with randomized clinical trials involving cancer patients. J Clin Ethics 3:231-234, 1992
110. Taylor KM, Margolese RG, Soskolne CL: Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 310:1363-1367, 1984
111. Taylor KM, Shapiro M, Soskolne CL, et al: Physician response to informed consent regulations for randomized clinical trials. Cancer 60:1415-1422, 1987
112. Fetting JH, Simonoff LA, Piantodosi S, et al: The effects of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: A clinical vignette study. J Clin Oncol 8:1476-1482, 1990
113. Silverman WA, Altman DG: Patients' preferences and randomized trials. Lancet 347:171-174, 1996
114. Cassileth BR, Lusk ES, Hurwitz S, et al: Attitudes towards clinical trials among patients and the public. JAMA 248:968-970, 1982
115. Slevin MJ, Stubb L, Plant HJ, et al: Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and the general public. BMJ 300:1458-1460, 1990
116. Taylor KM, Feldstein ML, Skeel RT, et al: Fundamental dilemmas of the randomized clinical trial process: Results of a survey of 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 12:1796-1805, 1994
117. Lynoe N, Sandland M, Jacobson L: Cancer clinical research: Some aspects on doctors' attitudes to informing participants. Acta Oncol 35:749-754, 1996
118. Royall RM: Ignorance and altruism. J Clin Ethics 3:229-230, 1992
119. Gallo C, Perrone F, Deplando S, et al: Informed versus randomized consent to clinical trials. Lancet 346:1060-1064, 1995
120. Simel DL, Feussner JR: A randomized controlled trial comparing quantitative informed consent formats. J Clin Epidemiol 44:771-777, 1991
121. Baum M: New approach for recruitment into randomized controlled trials. Lancet 341:812-813, 1993
122. Altman DG, Whitehead J, Parman MK, et al: Consent designs in cancer clinical trials. Eur J Cancer 31A: 1934-1944, 1995
123. Zelen M: Strategy and alternate randomized designs in cancer clinical trials. Cancer Treat Rep 66:1095-1100, 1982
124. Riethmuller G, Schneider-Gadicke E, Schilmok G, et al: Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343:1177-1183, 1994
125. Mansour EG, Gray R, Shatila AH, et al: Efficacy of adjuvant chemotherapy of high-risk node-negative breast cancer. N Engl J Med 320:485-490, 1989
126. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
127. Daugherty CK, Ratain MJ, Siegler M et al: Learning from our patients: One subject's impact on clinical trial research and informed consent. Ann Intern Med 126:892-897, 1997
128. Daugherty CK, Ratain MJ, Minami H, et al: Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol 16:2305-2312, 1998
129. Marsoni S, Hoth D, Simon R, et al: Clinical drug development: An analysis of phase II trials, 1970-1985. Cancer Treat Rep 71:71-80, 1987
130. Fallowfield L, Lipkin M, Hall A: Teaching senior oncologists communication skills: Results from phase I of a comprehensive longitudinal program in the United Kingdom. J Clin Oncol 16:1961-1968, 1998
131. Kelly WD, Friesen SR: Do cancer patients want to be told? Surgery 27:822-826, 1950
132. Oken D: What to tell cancer patients: A study of medical attitudes. JAMA 175:1120-1128, 1961
133. Novack DH, Plumer R, Smith RL, et al: Changes in physicians' attitudes toward telling the cancer patient. JAMA 241:897-900, 1979
134. McIntosh J: Patients' awareness and desire for information about diagnosed but undisclosed malignant disease. Lancet 2:300-303, 1976
135. McIntosh J: Processes of communication, information-seeking and control associated with cancer. Soc Sci Med 8:167-187, 1974
136. Cassileth BR, Zupkis RV, Sutton-Smith K, et al: Information and participation preferences among cancer patients. Ann Intern Med 92:832-836, 1980
137. McNeil BJ, Pauker SG, Sox HC, et al: On the elicitation of preferences for alternative therapies. N Engl J Med 306:1259-1262, 1982
138. Mackillop WJ, Stewart WE, Ginsburg AD, et al: Cancer patients' perceptions of their disease and its treatment. Br J Cancer 58:355-358, 1988
139. Reynolds PM, Sanson-Fisher RW, Poole AD, et al: Cancer and communication: Information-giving in on oncology clinic. Br Med J 282:1449-1451, 1981
140. Ende J, Kazis L, Ash A, et al: Measuring patients' desire for autonomy: Decision-making and information-seeking preferences among medical patients. J Gen Intern Med 4:23-30, 1989
141. O'Connor AM: Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol 42:119-126, 1989
142. Levine MN, Gafni A, Markham B, et al: A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117:53-58, 1992
143. Llewellyn-Thomas HK, McGreal MJ. Thiel EC. et al: Patients' willingness to enter clinical trials: Measuring the association with perceived benefits and preference for decision participation. Soc Sci Med 32:35-42, 1992
144. Llewellyn-Thomas HK, McGreal MJ, Thiel EC: Cancer patients' decision-making and trial-entry preferences: The effects of "framing" information about short-term toxicity and long-term survival. Med Decis Making 15:4-12, 1995
145. Hux J, Naylor CD: Does the format of efficacy data determine patients'acceptance of treatment? Med Decis Making 15:152-159, 1995
146. Chapman GB, Elstein AS, Hughes KK: Effects of patient education on decisions about breast cancer treatments: A preliminary report. Med Decis Making 15:231-239, 1995
147. Dunn SM, Patterson PU, Butow PN, et al: Cancer by another name: A randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients. J Clin Oncol 11:989-996, 1993
148. McQuellon RP, Muss HB, Hoffman SL, et al: Patient preferences for treatment of metastatic breast cancer: A study of women with early stage breast cancer. J Clin Oncol 13:858-868, 1995
149. Turner S, Maher EJ, Young T, et al: What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease. Br J Cancer 73:222-227, 1996
150. Wei JP, Sherry RM, Baisden BL, et al: Prospective hospital-based survey of attitudes of southern woman toward surgical treatment of breast cancer. Ann Surg Oncol 2:360-364, 1995
151. Mazur DJ, Merz JF: How older patients' treatment preferences are influenced by disclosure about therapeutic uncertainty: Surgery versus expectant management for localized prostate cancer. J Am Geriatr Soc 44:934-937, 1996
152. Stiggelbout AM, deHaes JC, Kiebert GM, et al: Trade-offs between quality and quantity of life: Development of the QQ questionnaire for cancer patients' attitudes. Med Decis Making 16:184-192, 1996
153. Palda VA, Llewellyn-Thomas HA, Mackenzie RG, et al: Breast cancer patients' attitudes about rationing host lumpectomy radiation therapy: Applicability of trade-off methods to policy-making. J Clin Oncol 15:3192-3200, 1997
154. Degner LF, Sloan JA: Decision-making during serious illness: What role do patients really want to play? J Clin Epidemiol 45:941-950, 1992
155. Lindley C, Vasa S, Sawyer WT, et al: Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:1380-1387, 1998
156. Redmond K: Assessing patients' needs and preferences in the management of advanced colorectal cancer. Br J Cancer 77:5-7, 1998 (suppl 2)
157. Sulmasy DP, Terry PB, Weisman CS, et al: The accuracy of substituted judgements in patients with terminal diagnoses Ann Intern Med 128:621-629, 1998
158. Weeks JC, Cook EF, O'Day SJ, et al: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714, 1998